J Public Health (2009) 17:71–76	51.02360153198242	32.8875732421875	8.4737548828125	112.55592727661133	0	NPGGFA+AdvTT3713a231
DOI 10.1007/s10389-008-0218-5	51.02360534667969	44.339111328125	8.46820068359375	113.98025512695312	0	NPGGFA+AdvTT3713a231
ORIGINAL ARTICLE	56.692901611328125	64.28326416015625	10.460693359375	96.75416564941406	1	NPGGFA+AdvTT3713a231
Parents’ attitudes towards varicella vaccination acceptance	51.02360153198242	106.78546142578125	17.4073486328125	440.7515754699707	2	NPGGFB+AdvTTb8864ccf.B
in France and Germany: effect of vaccine recommendation	51.02533721923828	126.7410888671875	17.36480712890625	441.7813034057617	2	NPGGFB+AdvTTb8864ccf.B
and reimbursement (a survey)	51.02533721923828	146.64117431640625	17.36480712890625	226.01326751708984	2	NPGGFB+AdvTTb8864ccf.B
François-André Allaert & Antoine Blanc & Yves Megard &	51.02360153198242	182.246337890625	9.962646484375	235.77254104614258	3	NPGGGC+AdvP0005
Isabelle Bertand	51.02360153198242	194.71881103515625	9.962646484375	70.2114143371582	3	NPGGFB+AdvTTb8864ccf.B
Received: 13 February 2008 / Accepted: 15 July 2008 / Published online: 30 August 2008	51.02360153198242	242.7646484375	8.46820068359375	308.3398628234863	4	NPGGFA+AdvTT3713a231
# Springer-Verlag 2008	51.02360153198242	252.74273681640625	8.69598388671875	84.34412002563477	4	NPGGGD+AdvPi3
Abstract	51.02360153198242	282.36602783203125	9.96258544921875	36.6932487487793	5	NPGGFB+AdvTTb8864ccf.B
Aims To ascertain physicians’ and parents’ attitudes to-	51.02360153198242	294.2942810058594	10.0208740234375	238.04536819458008	5	NPGGGE+AdvTT50a2f13e.I
wards varicella vaccination acceptance and to compare	51.022613525390625	306.8181457519531	9.96258544921875	238.07223510742188	5	NPGGFA+AdvTT3713a231
them between Germany (G), where routine varicella	51.022613525390625	319.2903137207031	9.96258544921875	238.1151123046875	5	NPGGFA+AdvTT3713a231
vaccination is recommended in children, and France (F),	51.022613525390625	331.7057189941406	9.96258544921875	238.05633544921875	5	NPGGFA+AdvTT3713a231
where it is not.	51.022613525390625	344.1778869628906	9.96258544921875	61.06376647949219	5	NPGGFA+AdvTT3713a231
Methods Study design: cross-sectional pharmacoepidemio-	51.022613525390625	356.0882873535156	10.0142822265625	238.08419799804688	5	NPGGGE+AdvTT50a2f13e.I
logical study conducted in pediatric practice. Data included	51.02261734008789	368.5553894042969	9.96258544921875	238.20473861694336	5	NPGGFA+AdvTT3713a231
descriptions of the vaccinated children by pediatricians and	51.02261734008789	381.0275573730469	9.96258544921875	238.10000228881836	5	NPGGFA+AdvTT3713a231
descriptions of the parents’ attitudes using a self-administered	51.02261734008789	393.4997253417969	9.96917724609375	238.20080184936523	5	NPGGFA+AdvTT3713a231
questionnaire. The next five successive children, under	51.022621154785156	405.9151306152344	9.96258544921875	238.07231903076172	5	NPGGFA+AdvTT3713a231
15 years old, vaccinated against varicella were included in	51.022621154785156	418.3872985839844	9.96258544921875	238.18474578857422	5	NPGGFA+AdvTT3713a231
the study.	51.022621154785156	430.8594665527344	9.96258544921875	37.35576629638672	5	NPGGFA+AdvTT3713a231
Results Six hundred ninety-five pediatricians (F: 186; G:	51.022621154785156	442.7698669433594	10.0142822265625	238.08623504638672	5	NPGGGE+AdvTT50a2f13e.I
509) and 2,593 parents (F: 664; G: 1,929) were included in	51.02262496948242	455.2369689941406	9.96258544921875	238.06926345825195	5	NPGGFA+AdvTT3713a231
the study. Initially, 7.1% of the German parents and 15.3%	51.02262496948242	467.7091369628906	9.96258544921875	238.07423782348633	5	NPGGFA+AdvTT3713a231
of the French parents were reluctant to have their children	51.02262496948242	480.1813049316406	9.96258544921875	238.09413528442383	5	NPGGFA+AdvTT3713a231
inoculated with the varicella vaccine (p < 0.0001). The	51.02262496948242	492.5967102050781	9.96258544921875	238.08424758911133	5	NPGGFA+AdvTT3713a231
main reason for their reluctance was the ‘fear of	51.02262496948242	505.06890869140625	9.96917724609375	238.08122634887695	5	NPGGFA+AdvTT3713a231
complications due to the vaccination’ in both countries	51.022613525390625	517.5410766601562	9.969146728515625	238.11810302734375	5	NPGGFA+AdvTT3713a231
(G: 60.0% vs 55.5%; p: ns). Fewer German parents	51.022613525390625	529.9564819335938	9.962600708007812	238.08026123046875	5	NPGGFA+AdvTT3713a231
thought that the varicella vaccine was too recent (5.9%	51.022613525390625	542.4286499023438	9.962600708007812	238.1021728515625	5	NPGGFA+AdvTT3713a231
F.-A. Allaert (*)	51.02360153198242	587.4407348632812	8.5416259765625	59.98618698120117	6	NPGGFA+AdvTT3713a231
Department of Medical Evaluation, Ceren ESC and Cenbiotech,	51.02360153198242	597.4922485351562	8.46820068359375	219.9699592590332	6	NPGGFA+AdvTT3713a231
24 bd Jeanne d’Arc,	51.02360153198242	607.4702758789062	8.47381591796875	69.78643417358398	6	NPGGFA+AdvTT3713a231
21000 Dijon, France	51.02360153198242	617.4483642578125	8.46820068359375	70.75603103637695	6	NPGGFA+AdvTT3713a231
e-mail: stat@cenbiotech.com	51.02360153198242	627.3696899414062	8.46820068359375	98.53680801391602	6	NPGGFA+AdvTT3713a231
F.-A. Allaert	51.02360153198242	647.3258666992188	8.46820068359375	42.966800689697266	7	NPGGFA+AdvTT3713a231
Department of Epidemiology, McGill University,	51.02360153198242	657.2471923828125	8.46820068359375	168.0573616027832	7	NPGGFA+AdvTT3713a231
Montreal, QC, Canada	51.02360153198242	667.2252807617188	8.46820068359375	77.48064041137695	7	NPGGFA+AdvTT3713a231
A. Blanc : Y. Megard : I. Bertand	51.02360153198242	682.6443481445312	13.00531005859375	113.71615982055664	8	NPGGJG+AdvP4C4E51
Sanofi-Pasteur MSD,	51.02368927001953	697.1015625	8.46820068359375	72.40988159179688	8	NPGGFA+AdvTT3713a231
Lyon, France	51.02368927001953	707.0796508789062	8.46820068359375	45.017791748046875	8	NPGGFA+AdvTT3713a231
vs 45.5%; p < 0.0001), and they were also less reluctant	306.139892578125	282.3798522949219	9.96258544921875	238.05126953125	9	NPGGFA+AdvTT3713a231
due to the cost of the vaccination (G: 11.9% vs F:22.8%;	306.139892578125	294.8520202636719	9.96258544921875	238.15692138671875	9	NPGGFA+AdvTT3713a231
p< 0.02). In both countries, the most convincing arguments	306.139892578125	307.3241882324219	9.96258544921875	238.087158203125	9	NPGGFA+AdvTT3713a231
for parents who were initially reluctant were ‘information on	306.139892578125	319.7395935058594	9.96917724609375	238.20587158203125	9	NPGGFA+AdvTT3713a231
the potential seriousness of the disease,’ which was reported	306.139892578125	332.2117614746094	9.96917724609375	238.2047119140625	9	NPGGFA+AdvTT3713a231
by three-quarters of the parents (G: 70.0% vs F: 74.3%;	306.13983154296875	344.6839294433594	9.96258544921875	238.15997314453125	9	NPGGFA+AdvTT3713a231
p: ns), and ‘availability of an effective, well-tolerated	306.13983154296875	357.0993347167969	9.96917724609375	238.0902099609375	9	NPGGFA+AdvTT3713a231
vaccine’ (G: 59.4% vs F: 64.0%; p: ns).	306.13983154296875	369.5715026855469	9.96917724609375	159.84689331054688	9	NPGGFA+AdvTT3713a231
Conclusion Even in the absence of an official recommen-	306.1398010253906	381.4819030761719	10.0142822265625	237.98855590820312	9	NPGGGE+AdvTT50a2f13e.I
dation, French parents will accept varicella vaccine to the	306.1398010253906	394.0057678222656	9.96258544921875	238.05728149414062	9	NPGGFA+AdvTT3713a231
same extent as German parents where it is advisable if they	306.1398010253906	406.4211730957031	9.96258544921875	238.04934692382812	9	NPGGFA+AdvTT3713a231
receive appropriate information about the potential severity	306.1398010253906	418.8933410644531	9.96258544921875	238.01950073242188	9	NPGGFA+AdvTT3713a231
of the disease and the efficacy and safety of the vaccine.	306.1398010253906	431.3087463378906	9.96258544921875	230.32443237304688	9	NPGGFA+AdvTT3713a231
Keywords Varicella vaccination . General practice .	306.1398010253906	454.2685546875	11.9471435546875	204.20343017578125	10	NPGGFB+AdvTTb8864ccf.B
Parents’ attitude	306.13983154296875	468.6684875488281	9.96917724609375	63.654052734375	10	NPGGFA+AdvTT3713a231
Introduction	306.13983154296875	506.01141357421875	9.96258544921875	53.6087646484375	11	NPGGFB+AdvTTb8864ccf.B
Many studies have shown that vaccines can protect children	306.13983154296875	530.9736328125	9.962600708007812	238.032470703125	12	NPGGFA+AdvTT3713a231
and adults from bacterial and viral infections. Vaccination	306.13983154296875	543.3889770507812	9.962600708007812	238.08721923828125	12	NPGGFA+AdvTT3713a231
has led to important reductions in the incidences of several	306.13983154296875	555.8612060546875	9.962600708007812	238.0772705078125	12	NPGGFA+AdvTT3713a231
diseases and even eradication in same instances, for	306.13983154296875	568.3333740234375	9.962600708007812	238.1011962890625	12	NPGGFA+AdvTT3713a231
example, small pox. Despite their proven effectiveness,	306.13983154296875	580.748779296875	9.962600708007812	238.05133056640625	12	NPGGFA+AdvTT3713a231
many children do not receive vaccines because of their	306.13983154296875	593.220947265625	9.962600708007812	238.059326171875	12	NPGGFA+AdvTT3713a231
parents’ philosophy or religious beliefs, their concerns	306.13983154296875	605.693115234375	9.969192504882812	238.08721923828125	12	NPGGFA+AdvTT3713a231
about costs, or doubts about the usefulness, safety, or	306.13885498046875	618.1085205078125	9.962600708007812	238.07733154296875	12	NPGGFA+AdvTT3713a231
efficacy of vaccines (Poland and Jacobson 2001; Taylor et	306.13885498046875	630.5806884765625	9.962600708007812	238.06622314453125	12	NPGGFA+AdvTT3713a231
al. 2002; Alfredsson et al. 2004; Fredrickson et al. 2004;	306.13885498046875	643.0529174804688	9.962600708007812	238.07818603515625	12	NPGGFA+AdvTT3713a231
Freed et al. 2004). Reluctance to use vaccines has been	306.1388244628906	655.46826171875	9.962600708007812	238.06930541992188	12	NPGGFA+AdvTT3713a231
fueled by reports of alleged adverse events from vaccines	306.13885498046875	667.9404296875	9.962600708007812	238.07623291015625	12	NPGGFA+AdvTT3713a231
spread by anti-vaccination web sites, as well as by recent	306.13885498046875	680.41259765625	9.962600708007812	238.01043701171875	12	NPGGFA+AdvTT3713a231
vaccine recalls and modifications (Freed et al. 1996; Wolfe	306.13885498046875	692.8280029296875	9.962600708007812	238.03533935546875	12	NPGGFA+AdvTT3713a231
et al. 2002; Flanagan-Klygis et al. 2005). The situation is	306.1387939453125	705.3001708984375	9.962600708007812	238.0582275390625	12	NPGGFA+AdvTT3713a231
DO00218; No of Pages	468.2267150878906	776.6445922851562	7.970200538635254	76.01980590820312	13	NPGGFA+AdvTT3713a231
72	51.02360153198242	33.05755615234375	8.46820068359375	8.46820068359375	14	NPGGFA+AdvTT3713a231
worse when the vaccine is not universally recommended,	51.02360153198242	58.33349609375	9.96258544921875	238.09712600708008	15	NPGGFA+AdvTT3713a231
and even when a vaccine is recommended, not all	51.02360153198242	70.7489013671875	9.96258544921875	238.07527542114258	15	NPGGFA+AdvTT3713a231
physicians immediately adopt it in routine use.	51.02360153198242	83.2210693359375	9.96258544921875	189.5932502746582	15	NPGGFA+AdvTT3713a231
Varicella vaccine is one example for which these issues	62.362037658691406	95.6932373046875	9.96258544921875	226.71788787841797	15	NPGGFA+AdvTT3713a231
have slowed uptake. In the US, varicella vaccination has	51.02360153198242	108.108642578125	9.96258544921875	238.06929397583008	15	NPGGFA+AdvTT3713a231
been recommended since 1996, but it took nearly 5 years to	51.02360153198242	120.580810546875	9.96258544921875	238.06926345825195	15	NPGGFA+AdvTT3713a231
reach satisfactory coverage of more than 80% of children	51.02360153198242	133.052978515625	9.96258544921875	238.03236770629883	15	NPGGFA+AdvTT3713a231
(Sengupta et al. 2007). This vaccination has led to a	51.02360153198242	145.4683837890625	9.96258544921875	238.09721755981445	15	NPGGFA+AdvTT3713a231
reduction in the incidence of varicella of about 75% (CDC	51.02459716796875	157.9405517578125	9.96258544921875	238.04141235351562	15	NPGGFA+AdvTT3713a231
2003). Doctors must be ready to answer parents’ questions	51.02459716796875	170.4127197265625	9.96917724609375	238.02243041992188	15	NPGGFA+AdvTT3713a231
and address misconceptions since parental beliefs may be a	51.02557373046875	182.828125	9.96258544921875	238.09518432617188	15	NPGGFA+AdvTT3713a231
major factor influencing whether a child receives the	51.02557373046875	195.30029296875	9.96258544921875	238.10116577148438	15	NPGGFA+AdvTT3713a231
varicella vaccine (Taylor and Newman 2000).	51.02557373046875	207.7724609375	9.96258544921875	185.07423400878906	15	NPGGFA+AdvTT3713a231
The varicella vaccine is being increasingly used through-	62.364013671875	220.1878662109375	9.96258544921875	226.73080444335938	15	NPGGFA+AdvTT3713a231
out Europe, although with different administrative and	51.025577545166016	232.6600341796875	9.96258544921875	238.07921981811523	15	NPGGFA+AdvTT3713a231
regulatory modalities. For example, in France, the varicella	51.025577545166016	245.1322021484375	9.96258544921875	238.07827377319336	15	NPGGFA+AdvTT3713a231
vaccine has been registered since December 2003, but there	51.025577545166016	257.547607421875	9.96258544921875	238.0214500427246	15	NPGGFA+AdvTT3713a231
are no national recommendations for its routine use in	51.025577545166016	270.0197448730469	9.96258544921875	238.0693016052246	15	NPGGFA+AdvTT3713a231
children. Recommendations exist for health-care and child-	51.025577545166016	282.4919128417969	9.96258544921875	238.05035018920898	15	NPGGFA+AdvTT3713a231
care workers, those who have close contacts with immu-	51.025577545166016	294.9073181152344	9.96258544921875	238.02343368530273	15	NPGGFA+AdvTT3713a231
nocompromised people, and children requiring a solid	51.025577545166016	307.3794860839844	9.96258544921875	238.03432846069336	15	NPGGFA+AdvTT3713a231
organ transplant, and for people, at least 18 years old,	51.025577545166016	319.8516540527344	9.96258544921875	238.0563621520996	15	NPGGFA+AdvTT3713a231
within 3 days of contact with an infected person. In	51.025577545166016	332.2670593261719	9.96258544921875	238.07622909545898	15	NPGGFA+AdvTT3713a231
addition, this vaccine is not reimbursed by the health-care	51.025577545166016	344.7392272949219	9.96258544921875	238.0951805114746	15	NPGGFA+AdvTT3713a231
insurance system. In contrast, in Germany, routine admin-	51.025577545166016	357.1546325683594	9.96258544921875	238.04238510131836	15	NPGGFA+AdvTT3713a231
istration to healthy children has been officially recommen-	51.025577545166016	369.6268005371094	9.96258544921875	237.98858261108398	15	NPGGFA+AdvTT3713a231
ded since July 2004, and it is reimbursed in most	51.025577545166016	382.0989685058594	9.96258544921875	238.06631088256836	15	NPGGFA+AdvTT3713a231
administrative areas (Rasch and Hellenbrand 2004). Thus,	51.025577545166016	394.5143737792969	9.96258544921875	238.07928085327148	15	NPGGFA+AdvTT3713a231
Germany and France provide an interesting comparison for	51.02659606933594	406.9865417480469	9.96258544921875	238.0523223876953	15	NPGGFA+AdvTT3713a231
studying the effect of recommendations and funding on the	51.02659606933594	419.4587097167969	9.96258544921875	238.0573272705078	15	NPGGFA+AdvTT3713a231
attitudes of parents concerning varicella vaccination. For	51.02659606933594	431.8741149902344	9.96258544921875	238.0772247314453	15	NPGGFA+AdvTT3713a231
this we surveyed parents of children that were vaccinated	51.02659606933594	444.3462829589844	9.96258544921875	238.0463409423828	15	NPGGFA+AdvTT3713a231
against varicella by private pediatricians or general practi-	51.02659606933594	456.8184509277344	9.96258544921875	238.0224151611328	15	NPGGFA+AdvTT3713a231
tioners in Germany and France between March 2005 and	51.02659606933594	469.2338562011719	9.96258544921875	238.07923889160156	15	NPGGFA+AdvTT3713a231
March 2006.	51.02659606933594	481.7060241699219	9.96258544921875	51.49867248535156	15	NPGGFA+AdvTT3713a231
Materials and methods	51.02659606933594	519.0488891601562	9.96258544921875	98.72039794921875	16	NPGGFB+AdvTTb8864ccf.B
The purpose of this cross-sectional study conducted	51.02659606933594	543.9544067382812	9.962600708007812	238.18382263183594	17	NPGGFA+AdvTT3713a231
between March 2005 and March 2006 was to ascertain	51.02659606933594	556.4265747070312	9.962600708007812	238.00352478027344	17	NPGGFA+AdvTT3713a231
physicians’ and parents’ attitudes towards varicella vacci-	51.02659606933594	568.8987426757812	9.969192504882812	238.0115203857422	17	NPGGFA+AdvTT3713a231
nation acceptance and to compare them between Germany	51.026588439941406	581.3141479492188	9.962600708007812	238.01647186279297	17	NPGGFA+AdvTT3713a231
(G), where routine varicella vaccination is recommended in	51.026588439941406	593.7863159179688	9.962600708007812	238.06822967529297	17	NPGGFA+AdvTT3713a231
children, and France (F), where it is not. Two samples of	51.026588439941406	606.2584838867188	9.962600708007812	238.07518768310547	17	NPGGFA+AdvTT3713a231
600 pediatricians (or GPs with essentially child-oriented	51.026588439941406	618.6738891601562	9.962600708007812	237.9995346069336	17	NPGGFA+AdvTT3713a231
practices) selected at random in France and Germany were	51.026588439941406	631.1460571289062	9.962600708007812	238.07125091552734	17	NPGGFA+AdvTT3713a231
involved. They were asked to include the next five	51.026588439941406	643.6182250976562	9.962600708007812	238.12102508544922	17	NPGGFA+AdvTT3713a231
successive children they vaccinated against varicella during	51.026588439941406	656.0336303710938	9.962600708007812	238.10213470458984	17	NPGGFA+AdvTT3713a231
the next month. These recruitment conditions led in each	51.026588439941406	668.5057983398438	9.962600708007812	238.06624603271484	17	NPGGFA+AdvTT3713a231
country to a sample of 3,000 cases providing a confidence	51.026588439941406	680.9779663085938	9.962600708007812	238.0593490600586	17	NPGGFA+AdvTT3713a231
interval of under 2% in case of an observed percentage	51.026588439941406	693.3933715820312	9.962600708007812	238.07527923583984	17	NPGGFA+AdvTT3713a231
under 5%. This choice was made due to the fact that we	51.026588439941406	705.8655395507812	9.962600708007812	238.04741668701172	17	NPGGFA+AdvTT3713a231
J Public Health (2009) 17:71–76	431.71575927734375	33.05755615234375	8.4737548828125	112.555908203125	18	NPGGFA+AdvTT3713a231
expected a low value for some questions, in particular for	306.14385986328125	58.32147216796875	9.96258544921875	238.05438232421875	19	NPGGFA+AdvTT3713a231
the spontaneous request for varicella vaccination, especially	306.14385986328125	70.73687744140625	9.96258544921875	238.08123779296875	19	NPGGFA+AdvTT3713a231
in France, where it is not reimbursed. These children had to	306.14385986328125	83.20904541015625	9.96258544921875	238.06927490234375	19	NPGGFA+AdvTT3713a231
be under 15 years of age and had to have no contra-	306.14385986328125	95.68121337890625	9.96258544921875	238.07427978515625	19	NPGGFA+AdvTT3713a231
indications to the vaccine. Information on the main	306.14385986328125	108.09661865234375	9.96258544921875	238.06231689453125	19	NPGGFA+AdvTT3713a231
demographic and clinical characteristics of the vaccinated	306.14385986328125	120.56878662109375	9.96258544921875	238.04541015625	19	NPGGFA+AdvTT3713a231
children as well as why the parents accepted the vaccination	306.14385986328125	133.04095458984375	9.96258544921875	238.0743408203125	19	NPGGFA+AdvTT3713a231
was recorded by the physician on the physician’s question-	306.14385986328125	145.45635986328125	9.96917724609375	238.0174560546875	19	NPGGFA+AdvTT3713a231
naire. Information on the parents’ attitudes concerning the	306.14385986328125	157.92852783203125	9.96917724609375	238.059326171875	19	NPGGFA+AdvTT3713a231
varicella vaccination was recorded on a self-administered	306.1448669433594	170.40069580078125	9.96258544921875	238.10018920898438	19	NPGGFA+AdvTT3713a231
questionnaire that the pediatrician gave them after having	306.1448669433594	182.81610107421875	9.96258544921875	238.03347778320312	19	NPGGFA+AdvTT3713a231
explained how to fill it in. This questionnaire was returned	306.1448669433594	195.28826904296875	9.96258544921875	238.08035278320312	19	NPGGFA+AdvTT3713a231
directly to the data analysis center in a prepaid envelope to	306.1448669433594	207.76043701171875	9.96258544921875	238.06930541992188	19	NPGGFA+AdvTT3713a231
protect anonymity. A common number included in the two	306.1448669433594	220.17584228515625	9.96258544921875	238.07931518554688	19	NPGGFA+AdvTT3713a231
documents allowed matching the pediatrician form with the	306.1448669433594	232.64801025390625	9.96258544921875	238.05630493164062	19	NPGGFA+AdvTT3713a231
self-administered questionnaire for the purposes of the	306.1448669433594	245.12017822265625	9.96258544921875	238.05538940429688	19	NPGGFA+AdvTT3713a231
statistical analysis.	306.1448669433594	257.53558349609375	9.96258544921875	74.60891723632812	19	NPGGFA+AdvTT3713a231
Results are expressed as means with their standard	317.4833068847656	270.0077209472656	9.96258544921875	226.72592163085938	19	NPGGFA+AdvTT3713a231
deviations for quantitative variables and by numbers and	306.1448669433594	282.4798889160156	9.96258544921875	238.08023071289062	19	NPGGFA+AdvTT3713a231
frequency distributions for qualitative variables. Chi-square	306.1448669433594	294.8952941894531	9.96258544921875	238.05331420898438	19	NPGGFA+AdvTT3713a231
analysis and analysis of variance were respectively per-	306.1448669433594	307.3674621582031	9.96258544921875	238.15597534179688	19	NPGGFA+AdvTT3713a231
formed to compare qualitative and quantitative values	306.1448669433594	319.8396301269531	9.96258544921875	238.09518432617188	19	NPGGFA+AdvTT3713a231
between France and Germany. A P-value of less than 0.05	306.1448669433594	332.2033386230469	10.0142822265625	238.08224487304688	19	NPGGGE+AdvTT50a2f13e.I
was considered to indicate statistical significance.	306.1448669433594	344.7272033691406	9.96258544921875	200.63284301757812	19	NPGGFA+AdvTT3713a231
Results	306.1448669433594	382.0700988769531	9.96258544921875	30.652923583984375	20	NPGGFB+AdvTTb8864ccf.B
Population and context of the vaccination	306.1448669433594	406.97552490234375	9.96258544921875	168.62600708007812	21	NPGGFA+AdvTT3713a231
Between March 2005 and March 2006, 509 German	306.1448669433594	431.86309814453125	9.96258544921875	238.11508178710938	22	NPGGFA+AdvTT3713a231
pediatricians participated in the study and only 186 French	306.1448669433594	444.33526611328125	9.96258544921875	238.04537963867188	22	NPGGFA+AdvTT3713a231
pediatricians because of some recruitment difficulties in	306.1448669433594	456.80743408203125	9.96258544921875	238.06735229492188	22	NPGGFA+AdvTT3713a231
relation to the absence of varicella vaccination recommen-	306.1448669433594	469.22283935546875	9.96258544921875	237.98855590820312	22	NPGGFA+AdvTT3713a231
dations in France. This point will be discussed. The	306.1448669433594	481.69500732421875	9.96258544921875	238.08016967773438	22	NPGGFA+AdvTT3713a231
questionnaire was given to the parents of 3,033 vaccinated	306.1448669433594	494.16717529296875	9.96258544921875	238.04641723632812	22	NPGGFA+AdvTT3713a231
children. A total of 2,593 questionnaires was returned	306.1448669433594	506.58258056640625	9.96258544921875	238.08029174804688	22	NPGGFA+AdvTT3713a231
(85.6% response rate; 1,929 from Germany and 664 from	306.1448669433594	519.0547485351562	9.96258544921875	238.07028198242188	22	NPGGFA+AdvTT3713a231
France). The mean age, percentage of girls, family size, and	306.1448669433594	531.5269775390625	9.962600708007812	238.08029174804688	22	NPGGFA+AdvTT3713a231
rank of the vaccinated children were similar for the two	306.1448669433594	543.9423217773438	9.962600708007812	238.07827758789062	22	NPGGFA+AdvTT3713a231
countries (Table 1). The only variable that was significantly	306.1448669433594	556.41455078125	9.962600708007812	238.06533813476562	22	NPGGFA+AdvTT3713a231
different was the parent’s education level: 36.1% of parents	306.1458740234375	568.88671875	9.969131469726562	238.06231689453125	22	NPGGFA+AdvTT3713a231
in Germany vs. 55.3% of parents in France were university	306.14691162109375	581.3021240234375	9.962600708007812	238.07330322265625	22	NPGGFA+AdvTT3713a231
or advanced technical college graduates (P< 0.0001).	306.14691162109375	593.7225952148438	10.014297485351562	213.60516357421875	22	NPGGGE+AdvTT50a2f13e.I
The rate of spontaneously requested varicella vaccina-	317.4853515625	606.2464599609375	9.962600708007812	226.73370361328125	22	NPGGFA+AdvTT3713a231
tion was significantly higher for German parents than for	306.14691162109375	618.661865234375	9.962600708007812	238.0533447265625	22	NPGGFA+AdvTT3713a231
French parents (20.9% vs 12.6%; P< 0.0001). As shown in	306.14691162109375	631.0823364257812	10.014297485351562	238.0692138671875	22	NPGGGE+AdvTT50a2f13e.I
Fig. 1, except for ‘avoid illness’ and ‘child living in close	306.14788818359375	643.6062622070312	9.993911743164062	238.020751953125	22	NPGGFA+AdvTT3713a231
contact with other children,’ which are the two main	306.1422424316406	656.04638671875	9.969192504882812	238.09927368164062	22	NPGGFA+AdvTT3713a231
reasons for spontaneous requests for vaccination, nearly	306.1422424316406	668.5186157226562	9.962600708007812	238.10018920898438	22	NPGGFA+AdvTT3713a231
all the other reasons given by parents were significantly	306.1422424316406	680.9907836914062	9.962600708007812	238.06234741210938	22	NPGGFA+AdvTT3713a231
different between the two countries: ‘Prevent complica-	306.1422424316406	693.4061279296875	9.969192504882812	237.98959350585938	22	NPGGFA+AdvTT3713a231
tions’ was mentioned more often in Germany than in	306.14227294921875	705.8783569335938	9.969131469726562	238.06927490234375	22	NPGGFA+AdvTT3713a231
J Public Health (2009) 17:71–76	51.02360153198242	33.05755615234375	8.4737548828125	112.55592727661133	23	NPGGFA+AdvTT3713a231
Table 1 Family characteristics of vaccinated children	51.02360153198242	57.02349853515625	8.4833984375	184.9531135559082	24	NPGGFB+AdvTTb8864ccf.B
Variable	51.02360153198242	75.52056884765625	8.46820068359375	27.851055145263672	25	NPGGFA+AdvTT3713a231
Childs’ age (years ± SD)	51.02360153198242	95.47674560546875	8.4737548828125	85.99202346801758	26	NPGGFA+AdvTT3713a231
Girls (%)	51.023597717285156	106.4752197265625	8.46820068359375	31.859909057617188	26	NPGGFA+AdvTT3713a231
Parents’ education: university or technical college graduate (%)	51.023597717285156	117.47369384765625	8.4737548828125	217.9832992553711	26	NPGGFA+AdvTT3713a231
Number of children in the family (mean ± SD)	51.023597717285156	128.5289306640625	8.46820068359375	161.84593963623047	26	NPGGFA+AdvTT3713a231
Rank of the vaccinated child (mean ± SD)	51.023597717285156	139.52740478515625	8.46820068359375	146.14250946044922	26	NPGGFA+AdvTT3713a231
SD: standard deviation; NS: not statistically significant	51.023597717285156	158.91619873046875	8.46820068359375	188.76123809814453	27	NPGGFA+AdvTT3713a231
Comparison between Germany and France	51.023597717285156	168.894287109375	8.46820068359375	146.38469696044922	27	NPGGFA+AdvTT3713a231
France (51.4% vs 41.5%; P < 0.01), and the difference was	51.02360153198242	205.00311279296875	10.0142822265625	238.08620071411133	28	NPGGGE+AdvTT50a2f13e.I
even larger for ‘information on the varicella vaccine in the	51.02361297607422	217.5269775390625	9.96917724609375	238.05731964111328	28	NPGGFA+AdvTT3713a231
media’ (42.3% vs 19.2%; P < 0.0001). The reasons for a	51.02361297607422	229.89068603515625	10.0208740234375	238.09720611572266	28	NPGGGE+AdvTT50a2f13e.I
spontaneous request for varicella vaccination were less	51.02362060546875	242.41455078125	9.96258544921875	238.08319091796875	28	NPGGFA+AdvTT3713a231
often in Germany than in France ‘avoid social and	51.02362060546875	254.88671875	9.96917724609375	238.08917236328125	28	NPGGFA+AdvTT3713a231
professional impact of child’s illness’ (29.1% vs 47.7%;	51.02262878417969	267.3021240234375	9.96917724609375	238.0194549560547	28	NPGGFA+AdvTT3713a231
P < 0.0001), ‘child’s relative currently has varicella’ (5.6%	51.02262878417969	279.7225646972656	10.0208740234375	238.03639221191406	28	NPGGGE+AdvTT50a2f13e.I
and 21.5%; P < 0.0001), and ‘avoid scarring’ (20.5% vs	51.02362060546875	292.1947326660156	10.0208740234375	238.08319091796875	28	NPGGGE+AdvTT50a2f13e.I
29.6%; p < 0.05).	51.02458190917969	304.6618347167969	9.96258544921875	67.0692138671875	28	NPGGFA+AdvTT3713a231
Parents’ opinions concerning varicella vaccination	51.02458190917969	329.606201171875	9.96917724609375	202.86940002441406	29	NPGGFA+AdvTT3713a231
The analysis of the parents’ questionnaire (Fig. 2) reveals	51.02457809448242	354.4947814941406	9.96917724609375	238.08919143676758	30	NPGGFA+AdvTT3713a231
that 7.1% of the German and 15.3% of the French parents	51.02458190917969	366.9669494628906	9.96258544921875	238.05931091308594	30	NPGGFA+AdvTT3713a231
were initially reluctant to allow their children to receive the	51.02458190917969	379.3823547363281	9.96258544921875	238.0553741455078	30	NPGGFA+AdvTT3713a231
varicella vaccine (P < 0.0001). The two main reasons for	51.02458190917969	391.8028259277344	10.0142822265625	238.05335998535156	30	NPGGGE+AdvTT50a2f13e.I
their reluctance were similar in the two countries, and both	51.02458190917969	404.3266906738281	9.96258544921875	238.05433654785156	30	NPGGFA+AdvTT3713a231
concerned the vaccination itself: ‘Complications following	51.02458190917969	416.7420959472656	9.96917724609375	238.0642547607422	30	NPGGFA+AdvTT3713a231
vaccination’ (G: 60.0% vs F: 55.5%; p: ns) and ‘too many	51.02458190917969	429.2142639160156	9.96917724609375	238.04335021972656	30	NPGGFA+AdvTT3713a231
vaccinations’ (G: 43.0% vs F: 40.6%; p: ns). The varicella	51.02557373046875	441.6864318847656	9.96917724609375	238.08023071289062	30	NPGGFA+AdvTT3713a231
Fig. 1 Reasons for parents’	51.02360153198242	484.1478271484375	8.48895263671875	110.55658340454102	31	NPGGFB+AdvTTb8864ccf.B
spontaneous request for	51.02360534667969	494.1410827636719	8.46820068359375	81.12026977539062	31	NPGGFA+AdvTT3713a231
varicella vaccination.	51.02360534667969	504.11920166015625	8.46820068359375	72.17955017089844	31	NPGGFA+AdvTT3713a231
Comparison between	51.02360534667969	514.04052734375	8.468170166015625	71.81710815429688	31	NPGGFA+AdvTT3713a231
Germany and France	51.02360534667969	524.0186157226562	8.46820068359375	71.71971130371094	31	NPGGFA+AdvTT3713a231
Germany	331.9366455078125	75.52056884765625	8.46820068359375	31.19683837890625	32	NPGGFA+AdvTT3713a231
3.3±3.1	331.9366455078125	95.47674560546875	8.46820068359375	27.13970947265625	33	NPGGFA+AdvTT3713a231
52.3	331.9366455078125	106.4752197265625	8.46820068359375	14.8193359375	33	NPGGFA+AdvTT3713a231
36.1	331.9374694824219	117.47369384765625	8.46820068359375	14.8193359375	33	NPGGFA+AdvTT3713a231
1.8±0.9	331.9358215332031	128.5289306640625	8.46820068359375	27.13970947265625	33	NPGGFA+AdvTT3713a231
1.6±0.8	331.9366455078125	139.52740478515625	8.46820068359375	27.13970947265625	33	NPGGFA+AdvTT3713a231
France	426.1038513183594	75.52056884765625	8.46820068359375	22.737091064453125	34	NPGGFA+AdvTT3713a231
3.3±3.1	426.1038513183594	95.47674560546875	8.46820068359375	27.13970947265625	35	NPGGFA+AdvTT3713a231
50.3	426.10302734375	106.4752197265625	8.46820068359375	14.8193359375	35	NPGGFA+AdvTT3713a231
55.3	426.10382080078125	117.47369384765625	8.46820068359375	14.8193359375	35	NPGGFA+AdvTT3713a231
1.7±1.0	426.10302734375	128.5289306640625	8.46820068359375	27.13970947265625	35	NPGGFA+AdvTT3713a231
1.7±0.8	426.1038513183594	139.52740478515625	8.46820068359375	27.13970947265625	35	NPGGFA+AdvTT3713a231
73	535.803466796875	33.05755615234375	8.46820068359375	8.4681396484375	36	NPGGFA+AdvTT3713a231
P	516.1885986328125	75.52056884765625	8.46820068359375	4.6744384765625	37	NPGGFA+AdvTT3713a231
NS	516.1885375976562	95.47674560546875	8.46820068359375	10.75457763671875	38	NPGGFA+AdvTT3713a231
NS	516.187744140625	106.4752197265625	8.46820068359375	10.75457763671875	38	NPGGFA+AdvTT3713a231
<0.0001	516.1885375976562	117.47369384765625	8.46820068359375	28.046630859375	38	NPGGFA+AdvTT3713a231
NS	516.187744140625	128.5289306640625	8.46820068359375	10.75457763671875	38	NPGGFA+AdvTT3713a231
NS	516.1885375976562	139.52740478515625	8.46820068359375	10.75457763671875	38	NPGGFA+AdvTT3713a231
vaccine was considered as being too recent by more French	306.142822265625	205.05181884765625	9.96258544921875	238.04638671875	39	NPGGFA+AdvTT3713a231
than German parents (G: 5.9% vs F: 45.5%; p < 0.0001).	306.142822265625	217.52398681640625	9.96258544921875	238.03839111328125	39	NPGGFA+AdvTT3713a231
Also, more French parents were reluctant due to the cost of	306.142822265625	229.93939208984375	9.96258544921875	238.0762939453125	39	NPGGFA+AdvTT3713a231
the vaccination (G: 11.9% vs F: 22.8%; p < 0.02) or because	306.142822265625	242.41156005859375	9.96258544921875	238.0264892578125	39	NPGGFA+AdvTT3713a231
they considered their child too young (G: 5.9% vs F:	306.142822265625	254.88372802734375	9.96258544921875	238.07513427734375	39	NPGGFA+AdvTT3713a231
13.9%; p < 0.05).	306.142822265625	267.29913330078125	9.96258544921875	67.06924438476562	39	NPGGFA+AdvTT3713a231
In both countries, the most convincing arguments for	317.48126220703125	279.7712707519531	9.96258544921875	226.71490478515625	39	NPGGFA+AdvTT3713a231
parents who were initially reluctant or who did not know	306.142822265625	292.2434387207031	9.96258544921875	238.0394287109375	39	NPGGFA+AdvTT3713a231
that a varicella vaccine existed were ‘information on the	306.142822265625	304.6588439941406	9.96917724609375	238.05828857421875	39	NPGGFA+AdvTT3713a231
potential seriousness of the disease,’ which was reported by	306.142822265625	317.1310119628906	9.96917724609375	238.09320068359375	39	NPGGFA+AdvTT3713a231
three-quarters of the parents, and ‘availability of an	306.142822265625	329.6031799316406	9.96917724609375	238.11712646484375	39	NPGGFA+AdvTT3713a231
effective, well-tolerated vaccine,’ which was mentioned	306.142822265625	342.0185852050781	9.96917724609375	238.010498046875	39	NPGGFA+AdvTT3713a231
by 59.4% and 64.0% of the parents in Germany and France,	306.143798828125	354.4907531738281	9.96258544921875	238.03936767578125	39	NPGGFA+AdvTT3713a231
respectively (p: ns) (Fig. 3). The other reasons, in	306.143798828125	366.9629211425781	9.96258544921875	238.12005615234375	39	NPGGFA+AdvTT3713a231
decreasing order of importance, were information that	306.143798828125	379.3783264160156	9.96258544921875	238.0782470703125	39	NPGGFA+AdvTT3713a231
‘varicella is frequent and contagious’ and ‘prevention of	306.143798828125	391.8504943847656	9.96917724609375	238.0782470703125	39	NPGGFA+AdvTT3713a231
varicella scars’ and ‘impact on the family of the disease.’	306.1448059082031	404.3226623535156	9.96917724609375	238.08517456054688	39	NPGGFA+AdvTT3713a231
Finally, the fact that vaccination is free of charge in	306.144775390625	416.7380676269531	9.96258544921875	238.068359375	39	NPGGFA+AdvTT3713a231
Germany was indicated as an advantage by 23.4% of the	306.144775390625	429.2102355957031	9.96258544921875	238.059326171875	39	NPGGFA+AdvTT3713a231
German parents.	306.144775390625	441.6824035644531	9.96258544921875	66.0799560546875	39	NPGGFA+AdvTT3713a231
74	51.02360153198242	33.05755615234375	8.46820068359375	8.46820068359375	40	NPGGFA+AdvTT3713a231
Fig. 2 Reasons for parents’	51.02360153198242	52.37469482421875	8.48895263671875	110.55658340454102	41	NPGGFB+AdvTTb8864ccf.B
initial reluctance to accept	51.02360534667969	62.36798095703125	8.46820068359375	89.97801208496094	41	NPGGFA+AdvTT3713a231
varicella vaccination.	51.02360534667969	72.289306640625	8.46820068359375	72.17955017089844	41	NPGGFA+AdvTT3713a231
Comparison between Germany	51.02360534667969	82.26739501953125	8.46820068359375	105.86181640625	41	NPGGFA+AdvTT3713a231
and France	51.02360534667969	92.2454833984375	8.46820068359375	37.70381164550781	41	NPGGFA+AdvTT3713a231
J Public Health (2009) 17:71–76	431.71575927734375	33.05755615234375	8.4737548828125	112.555908203125	42	NPGGFA+AdvTT3713a231
Discussion	51.02360153198242	294.49835205078125	9.96258544921875	44.46407699584961	43	NPGGFB+AdvTTb8864ccf.B
In the current study, we investigated parents’ attitudes to	51.02360153198242	319.40478515625	9.96917724609375	238.18486404418945	44	NPGGFA+AdvTT3713a231
accepting varicella vaccination between France and Germany	51.02459716796875	331.876953125	9.96258544921875	238.10311889648438	44	NPGGFA+AdvTT3713a231
and the best way to convince them to have their children	51.02459716796875	344.34912109375	9.96258544921875	238.20068359375	44	NPGGFA+AdvTT3713a231
vaccinated.	51.02459716796875	356.7645263671875	9.96258544921875	43.70591735839844	44	NPGGFA+AdvTT3713a231
The comparison with Germany was chosen because it	62.363033294677734	369.2366943359375	9.96258544921875	226.7627296447754	44	NPGGFA+AdvTT3713a231
was the first country in Europe that added varicella	51.02459716796875	381.7088623046875	9.96258544921875	238.04238891601562	44	NPGGFA+AdvTT3713a231
vaccination to the national routine vaccination schedule	51.02459716796875	394.124267578125	9.96258544921875	238.09722900390625	44	NPGGFA+AdvTT3713a231
for all children; it was the first country in the European	51.02459716796875	406.596435546875	9.96258544921875	238.03738403320312	44	NPGGFA+AdvTT3713a231
Union to do this. The Ständige Impfkommission (Standing	51.02459716796875	419.068603515625	9.96258544921875	238.09921264648438	44	NPGGFA+AdvTT3713a231
Committee on Vaccination, STIKO) at the Robert Koch	51.02459716796875	431.4840087890625	9.96258544921875	238.15594482421875	44	NPGGFA+AdvTT3713a231
Institute in Germany announced the change in their	51.02459716796875	443.9561767578125	9.96258544921875	238.05230712890625	44	NPGGFA+AdvTT3713a231
published update to the national vaccine schedule (Robert	51.02459716796875	456.4283447265625	9.96258544921875	238.06036376953125	44	NPGGFA+AdvTT3713a231
Koch-Institut 2004a, b). According to these official	306.1418762207031	294.5141906738281	9.96258544921875	238.02145385742188	45	NPGGFA+AdvTT3713a231
recommendations, varicella vaccination is scheduled for	306.14190673828125	306.9863586425781	9.96258544921875	238.14306640625	45	NPGGFA+AdvTT3713a231
infants aged between 11 and 14 months (given preferably	306.14190673828125	319.4017639160156	9.96258544921875	238.10015869140625	45	NPGGFA+AdvTT3713a231
at the same time as the MMR vaccine). Catch-up	306.14190673828125	331.8739318847656	9.96258544921875	238.1092529296875	45	NPGGFA+AdvTT3713a231
vaccination for children and adults is recommended, in	306.14190673828125	344.3460998535156	9.96258544921875	238.15301513671875	45	NPGGFA+AdvTT3713a231
particular for persons aged 9–17 years who have not had	306.14190673828125	356.7615051269531	9.96917724609375	238.09417724609375	45	NPGGFA+AdvTT3713a231
varicella infection. In France, no such recommendation	306.1418762207031	369.2336730957031	9.96258544921875	238.10317993164062	45	NPGGFA+AdvTT3713a231
exists, and the comparison with Germany was done in	306.1418762207031	381.7058410644531	9.96258544921875	238.03543090820312	45	NPGGFA+AdvTT3713a231
order to evaluate the impact of this recommendation and,	306.1418762207031	394.1212463378906	9.96258544921875	238.14486694335938	45	NPGGFA+AdvTT3713a231
moreover, to analyze if the existence a such recommen-	306.1418762207031	406.5934143066406	9.96258544921875	238.10415649414062	45	NPGGFA+AdvTT3713a231
dations was a sine qua non condition to the spreading of	306.1418762207031	419.0138854980469	10.0142822265625	238.07528686523438	45	NPGGGE+AdvTT50a2f13e.I
the varicella vaccine.	306.141845703125	431.4809875488281	9.96258544921875	86.9725341796875	45	NPGGFA+AdvTT3713a231
Potential biases should be considered before generalizing	317.48028564453125	443.9531555175781	9.96258544921875	226.73486328125	45	NPGGFA+AdvTT3713a231
the results to all parents of young children.	306.141845703125	456.4253234863281	9.96258544921875	174.67129516601562	45	NPGGFA+AdvTT3713a231
Fig. 3 Most convincing	51.02360153198242	484.1478271484375	8.483367919921875	83.58366775512695	46	NPGGFB+AdvTTb8864ccf.B
arguments in favor of varicella	51.023597717285156	494.1410827636719	8.46820068359375	105.78137969970703	46	NPGGFA+AdvTT3713a231
vaccination. Comparison	51.023597717285156	504.11920166015625	8.46820068359375	84.6108627319336	46	NPGGFA+AdvTT3713a231
between Germany and France	51.023597717285156	514.04052734375	8.468170166015625	102.5041732788086	46	NPGGFA+AdvTT3713a231
J Public Health (2009) 17:71–76	51.02360153198242	33.05755615234375	8.4737548828125	112.55592727661133	47	NPGGFA+AdvTT3713a231
The most important possible bias is that the physicians	62.36220169067383	58.33349609375	9.96258544921875	226.66901779174805	48	NPGGFA+AdvTT3713a231
who agreed to participate in the study may be those who are	51.023765563964844	70.7489013671875	9.96258544921875	238.06134796142578	48	NPGGFA+AdvTT3713a231
most in favor of varicella vaccination and therefore the	51.023765563964844	83.2210693359375	9.96258544921875	238.05731964111328	48	NPGGFA+AdvTT3713a231
most inclined to convince the parents. This bias is	51.023765563964844	95.6932373046875	9.96258544921875	238.09320831298828	48	NPGGFA+AdvTT3713a231
unavoidable, but its influence would be the same in both	51.023765563964844	108.108642578125	9.96258544921875	238.05432891845703	48	NPGGFA+AdvTT3713a231
countries. This potential bias may also have had some	51.023765563964844	120.580810546875	9.96258544921875	238.03043365478516	48	NPGGFA+AdvTT3713a231
impact on the parents’ opinion, but the effect would have	51.023765563964844	133.052978515625	9.96917724609375	238.0693130493164	48	NPGGFA+AdvTT3713a231
been minimal because the parents completed a strictly	51.023773193359375	145.4683837890625	9.96258544921875	238.08322143554688	48	NPGGFA+AdvTT3713a231
anonymous self-administered questionnaire that they sent	51.023773193359375	157.9405517578125	9.96258544921875	238.036376953125	48	NPGGFA+AdvTT3713a231
directly to the data analysis center.	51.023773193359375	170.4127197265625	9.96258544921875	140.47959899902344	48	NPGGFA+AdvTT3713a231
One other bias could be linked to the fact that the rate of	62.36220932006836	182.828125	9.96258544921875	226.74582290649414	48	NPGGFA+AdvTT3713a231
pediatricians participating to the study in France was much	51.023773193359375	195.30029296875	9.96258544921875	238.157958984375	48	NPGGFA+AdvTT3713a231
lower than in Germany. The lack of a recommendation in favor	51.023773193359375	207.7724609375	9.96258544921875	238.14700317382812	48	NPGGFA+AdvTT3713a231
of varicella vaccination in France (and consequently the	51.023773193359375	220.1878662109375	9.96258544921875	238.20672607421875	48	NPGGFA+AdvTT3713a231
absence of reimbursement) explains why many practitioners	51.023773193359375	232.6600341796875	9.96258544921875	238.08724975585938	48	NPGGFA+AdvTT3713a231
are still reluctant to propose it to parents and thus the difficulties	51.023773193359375	245.1322021484375	9.96258544921875	238.14794921875	48	NPGGFA+AdvTT3713a231
we met recruiting regular varicella vaccine prescribers. These	51.023773193359375	257.547607421875	9.96258544921875	238.109130859375	48	NPGGFA+AdvTT3713a231
recruitment difficulties have an unavoidable effect on the	51.023773193359375	270.0197448730469	9.96258544921875	238.13107299804688	48	NPGGFA+AdvTT3713a231
precision of the results, providing an average confidence	51.023773193359375	282.4919128417969	9.96258544921875	238.12005615234375	48	NPGGFA+AdvTT3713a231
interval of 2% for the German data and of 4% for the French	51.023773193359375	294.9073181152344	9.96258544921875	238.12603759765625	48	NPGGFA+AdvTT3713a231
data rather than the initially expected <2%. However,	51.023773193359375	307.3794860839844	9.96258544921875	238.10812377929688	48	NPGGFA+AdvTT3713a231
taking into account that the lowest percentage described for	51.023773193359375	319.8516540527344	9.96258544921875	238.1151123046875	48	NPGGFA+AdvTT3713a231
the French sample is 12.6% of spontaneously requested	51.023773193359375	332.2670593261719	9.96258544921875	238.09014892578125	48	NPGGFA+AdvTT3713a231
varicella vaccination, this precision of 4% still appears	51.023773193359375	344.7392272949219	9.96258544921875	238.13409423828125	48	NPGGFA+AdvTT3713a231
satisfactory.	51.023773193359375	357.1546325683594	9.96258544921875	48.42420959472656	48	NPGGFA+AdvTT3713a231
Another limit of our study is also due to the fact that we	62.36220932006836	369.6268005371094	9.96258544921875	226.70993423461914	48	NPGGFA+AdvTT3713a231
only considered vaccinated children, while it could have	51.023773193359375	382.0989685058594	9.96258544921875	238.06829833984375	48	NPGGFA+AdvTT3713a231
been interesting to describe the attitude and intentions from	51.023773193359375	394.5143737792969	9.96258544921875	238.0703125	48	NPGGFA+AdvTT3713a231
the parents who refused the vaccination of their child. This	51.023773193359375	406.9865417480469	9.96258544921875	238.05734252929688	48	NPGGFA+AdvTT3713a231
choice to focus our study on vaccination acceptance and	51.023773193359375	419.4587097167969	9.96258544921875	238.08026123046875	48	NPGGFA+AdvTT3713a231
eventual previous reluctance and not on refusal was	51.023773193359375	431.8741149902344	9.96258544921875	238.12908935546875	48	NPGGFA+AdvTT3713a231
dictated by the lack of recommendation for varicella	51.023773193359375	444.3462829589844	9.96258544921875	238.159912109375	48	NPGGFA+AdvTT3713a231
vaccination in France. Also, a written inquiry about the	51.023773193359375	456.8184509277344	9.96258544921875	238.05731201171875	48	NPGGFA+AdvTT3713a231
patient’s refusal could have been interpreted by the health	51.023773193359375	469.2338562011719	9.96917724609375	238.06130981445312	48	NPGGFA+AdvTT3713a231
authority as an unacceptable attempt to strongly influence	51.02278137207031	481.7060241699219	9.96258544921875	238.0204620361328	48	NPGGFA+AdvTT3713a231
them, and the rate of spontaneous answer would have been	51.02278137207031	494.1781921386719	9.96258544921875	238.06825256347656	48	NPGGFA+AdvTT3713a231
very low.	51.02278137207031	506.59356689453125	9.96258544921875	37.582916259765625	48	NPGGFA+AdvTT3713a231
Despite potential biases and limits, our results revealed	62.3612174987793	519.0657348632812	9.96258544921875	226.75078201293945	48	NPGGFA+AdvTT3713a231
that the presence of a recommendation for the vaccination	51.02278137207031	531.5379638671875	9.962600708007812	238.0752410888672	48	NPGGFA+AdvTT3713a231
in Germany and its absence in France have a major impact	51.02278137207031	543.953369140625	9.962600708007812	238.0314483642578	48	NPGGFA+AdvTT3713a231
on the parents’ knowledge about the disease and its	51.02278137207031	556.425537109375	9.969192504882812	238.13209533691406	48	NPGGFA+AdvTT3713a231
complications as well as on health-care promotion of the	51.02278137207031	568.8977661132812	9.962600708007812	238.0553436279297	48	NPGGFA+AdvTT3713a231
vaccine.	51.02278137207031	581.3131103515625	9.962600708007812	32.63946533203125	48	NPGGFA+AdvTT3713a231
A first remark concerns the educational level of the	62.3612174987793	593.7853393554688	9.962600708007812	226.71989822387695	48	NPGGFA+AdvTT3713a231
parents of the vaccinated children, which was higher in	51.02278137207031	606.2575073242188	9.962600708007812	238.0682830810547	48	NPGGFA+AdvTT3713a231
France than in Germany. This reflects that in France, due to	51.02278137207031	618.6729125976562	9.962600708007812	238.0682830810547	48	NPGGFA+AdvTT3713a231
the lack of official recommendation and of reimbursement,	51.02278137207031	631.1450805664062	9.962600708007812	238.10313415527344	48	NPGGFA+AdvTT3713a231
the educational level and the level of income of parents has	51.02278137207031	643.6172485351562	9.962600708007812	238.0692901611328	48	NPGGFA+AdvTT3713a231
a strong influence on the acceptance of varicella.	51.02278137207031	656.0326538085938	9.962600708007812	198.64524841308594	48	NPGGFA+AdvTT3713a231
Due to the availability of an official recommendation,	62.3612174987793	668.5048217773438	9.962600708007812	226.74477005004883	48	NPGGFA+AdvTT3713a231
more German parents were aware of the varicella vaccine	51.02278137207031	680.9769897460938	9.962600708007812	238.0951690673828	48	NPGGFA+AdvTT3713a231
and spontaneously requested vaccination. In addition, their	51.02278137207031	693.3923950195312	9.962600708007812	238.0583038330078	48	NPGGFA+AdvTT3713a231
reasons for requesting vaccination were different. German	51.02278137207031	705.8645629882812	9.962600708007812	238.0244598388672	48	NPGGFA+AdvTT3713a231
75	535.803466796875	33.05755615234375	8.46820068359375	8.4681396484375	49	NPGGFA+AdvTT3713a231
parents identified the main purpose of the vaccine as	306.14007568359375	58.32049560546875	9.96258544921875	238.07525634765625	50	NPGGFA+AdvTT3713a231
preventing complications and were convinced by information	306.14007568359375	70.73590087890625	9.96258544921875	238.1029052734375	50	NPGGFA+AdvTT3713a231
from the media, whereas the French parents’ motivations were	306.14007568359375	83.20806884765625	9.96917724609375	238.11907958984375	50	NPGGFA+AdvTT3713a231
linked to the social and professional consequences of the	306.14007568359375	95.68023681640625	9.96258544921875	238.09912109375	50	NPGGFA+AdvTT3713a231
disease, the prevention of infection of others, or the fear of	306.14007568359375	108.09564208984375	9.96258544921875	238.0611572265625	50	NPGGFA+AdvTT3713a231
scars. These findings suggest that even the French parents who	306.14007568359375	120.56781005859375	9.96258544921875	238.102294921875	50	NPGGFA+AdvTT3713a231
spontaneously requested the vaccine were not aware of the	306.14007568359375	133.03997802734375	9.96258544921875	238.09814453125	50	NPGGFA+AdvTT3713a231
seriousness of the complications of varicella. In Germany, the	306.14007568359375	145.45538330078125	9.96258544921875	238.09906005859375	50	NPGGFA+AdvTT3713a231
parents’ attitudes are similar to those described for parents in	306.14007568359375	157.92755126953125	9.96917724609375	238.10736083984375	50	NPGGFA+AdvTT3713a231
the US (Taylor and Newman 2000). In particular, when a	306.14007568359375	170.39971923828125	9.96258544921875	238.09814453125	50	NPGGFA+AdvTT3713a231
recommendation exists, parents are more convinced about the	306.14007568359375	182.81512451171875	9.96258544921875	238.0982666015625	50	NPGGFA+AdvTT3713a231
advantages of the vaccine to prevent serious complications	306.14007568359375	195.28729248046875	9.96258544921875	238.07928466796875	50	NPGGFA+AdvTT3713a231
than its ability to reduce time lost from work.	306.14007568359375	207.75946044921875	9.96258544921875	179.94570922851562	50	NPGGFA+AdvTT3713a231
The percentage of parents reluctant to accept varicella	317.478515625	220.17486572265625	9.96258544921875	226.73980712890625	50	NPGGFA+AdvTT3713a231
vaccination in the current study does not reflect the	306.14007568359375	232.64703369140625	9.96258544921875	238.10400390625	50	NPGGFA+AdvTT3713a231
percentage in the global population; it reflects the initial	306.14007568359375	245.11920166015625	9.96258544921875	238.0433349609375	50	NPGGFA+AdvTT3713a231
rate of reluctance of parents who finally agreed to have	306.14007568359375	257.53460693359375	9.96258544921875	238.06829833984375	50	NPGGFA+AdvTT3713a231
their children vaccinated. Thus, the percentages reported	306.14007568359375	270.0067443847656	9.96258544921875	238.087158203125	50	NPGGFA+AdvTT3713a231
here cannot be used as the basis for making conclusions	306.14007568359375	282.4789123535156	9.96258544921875	238.00250244140625	50	NPGGFA+AdvTT3713a231
about the reluctance for vaccination in the overall popula-	306.14007568359375	294.8943176269531	9.96258544921875	238.084228515625	50	NPGGFA+AdvTT3713a231
tion. The parents’ reluctance is mostly due to the fact that	306.14007568359375	307.3664855957031	9.96917724609375	238.082275390625	50	NPGGFA+AdvTT3713a231
they consider varicella to be a harmless disease and, above	306.14007568359375	319.8386535644531	9.96258544921875	238.060302734375	50	NPGGFA+AdvTT3713a231
all, fear of complications from the vaccine. The percentages	306.14007568359375	332.2540588378906	9.96258544921875	238.05633544921875	50	NPGGFA+AdvTT3713a231
of parents who were reluctant due to fear of complications	306.14007568359375	344.7262268066406	9.96258544921875	238.0125732421875	50	NPGGFA+AdvTT3713a231
of the vaccine (55.5% in France and 60.0% in Germany)	306.14007568359375	357.1416320800781	9.96258544921875	237.99261474609375	50	NPGGFA+AdvTT3713a231
are similar to that reported in the US (69%) (Salmon et al.	306.14007568359375	369.6138000488281	9.96258544921875	238.06231689453125	50	NPGGFA+AdvTT3713a231
2005). The high proportion of French parents who said they	306.14007568359375	382.0859680175781	9.96258544921875	238.05035400390625	50	NPGGFA+AdvTT3713a231
were reluctant because the varicella vaccine is too recent	306.14007568359375	394.5013732910156	9.96258544921875	238.0115966796875	50	NPGGFA+AdvTT3713a231
(45.5%) is surprising, but is probably due to the fact that	306.14007568359375	406.9735412597656	9.96258544921875	238.08123779296875	50	NPGGFA+AdvTT3713a231
since varicella vaccine is not officially recommended in	306.14007568359375	419.4457092285156	9.96258544921875	238.0682373046875	50	NPGGFA+AdvTT3713a231
France, little information on varicella vaccination is	306.14007568359375	431.8611145019531	9.96258544921875	238.0811767578125	50	NPGGFA+AdvTT3713a231
targeted to the general population. This is illustrated by	306.14007568359375	444.3332824707031	9.96258544921875	238.09326171875	50	NPGGFA+AdvTT3713a231
the fact that nearly half the French parents in our study	306.14007568359375	456.8054504394531	9.96258544921875	238.03448486328125	50	NPGGFA+AdvTT3713a231
were unaware that a varicella vaccine has been available for	306.14007568359375	469.2208557128906	9.96258544921875	238.0533447265625	50	NPGGFA+AdvTT3713a231
more than 10 years in the US, compared with 5.9% in	306.14007568359375	481.6930236816406	9.96258544921875	238.06829833984375	50	NPGGFA+AdvTT3713a231
Germany.	306.14007568359375	494.1651916503906	9.96258544921875	38.659881591796875	50	NPGGFA+AdvTT3713a231
Differences in reluctance to have children vaccinated due	317.478515625	506.58062744140625	9.96258544921875	226.7398681640625	50	NPGGFA+AdvTT3713a231
to cost were not as big as expected. However, this finding	306.14007568359375	519.0527954101562	9.96258544921875	238.04644775390625	50	NPGGFA+AdvTT3713a231
may be biased by the socioeconomic profile of the French	306.14007568359375	531.5249633789062	9.962600708007812	238.04638671875	50	NPGGFA+AdvTT3713a231
participants; on average, they have a higher educational	306.14007568359375	543.9403686523438	9.962600708007812	238.07427978515625	50	NPGGFA+AdvTT3713a231
level and therefore a higher income than their German	306.14007568359375	556.4125366210938	9.962600708007812	238.02447509765625	50	NPGGFA+AdvTT3713a231
counterparts. We cannot, therefore, conclude that French	306.14007568359375	568.8847045898438	9.962600708007812	238.04638671875	50	NPGGFA+AdvTT3713a231
parents are probably more willing to pay than German	306.14007568359375	581.3001098632812	9.962600708007812	238.0245361328125	50	NPGGFA+AdvTT3713a231
parents. This finding could suggest that, in the absence of	306.14007568359375	593.7722778320312	9.962600708007812	238.0762939453125	50	NPGGFA+AdvTT3713a231
reimbursement, the use of the vaccine will be dependent on	306.14007568359375	606.2445068359375	9.962600708007812	238.09222412109375	50	NPGGFA+AdvTT3713a231
the parents’ incomes.	306.14007568359375	618.6598510742188	9.969192504882812	85.79794311523438	50	NPGGFA+AdvTT3713a231
Our results show that in both countries the most	317.478515625	631.132080078125	9.962600708007812	226.74176025390625	50	NPGGFA+AdvTT3713a231
convincing argument in favor of the varicella vaccine is	306.14007568359375	643.604248046875	9.962600708007812	238.0572509765625	50	NPGGFA+AdvTT3713a231
the information given by the practitioner regarding the	306.14007568359375	656.0196533203125	9.962600708007812	238.0552978515625	50	NPGGFA+AdvTT3713a231
seriousness of the disease and the availability of a well-	306.14007568359375	668.4918212890625	9.962600708007812	238.01849365234375	50	NPGGFA+AdvTT3713a231
tolerated vaccine. The results from a study in the US, where	306.14007568359375	680.9639892578125	9.962600708007812	238.0643310546875	50	NPGGFA+AdvTT3713a231
the varicella vaccine has been recommended for more than	306.14007568359375	693.37939453125	9.962600708007812	238.0484619140625	50	NPGGFA+AdvTT3713a231
10 years, were similar; the most frequent factor influencing	306.1416931152344	705.8798217773438	9.962600708007812	238.09225463867188	50	NPGGFA+AdvTT3713a231
76	51.02360153198242	33.05755615234375	8.46820068359375	8.46820068359375	51	NPGGFA+AdvTT3713a231
parents’ decision was their doctor’s advice (Freeman and	51.02360153198242	58.33349609375	9.96917724609375	238.08122634887695	52	NPGGFA+AdvTT3713a231
Freed 1999).	51.023590087890625	70.7489013671875	9.96258544921875	51.39305877685547	52	NPGGFA+AdvTT3713a231
In summary, our results show that both German and	62.362022399902344	83.2210693359375	9.96258544921875	226.7417984008789	52	NPGGFA+AdvTT3713a231
French parents readily accepted varicella vaccination when	51.02358627319336	95.6932373046875	9.96258544921875	238.03537368774414	52	NPGGFA+AdvTT3713a231
the practitioner recommended it and/or when they were	51.02358627319336	108.108642578125	9.96258544921875	238.07028579711914	52	NPGGFA+AdvTT3713a231
appropriately informed about the potential severity of	51.02358627319336	120.580810546875	9.96258544921875	238.09418106079102	52	NPGGFA+AdvTT3713a231
varicella disease and the safety of the vaccine, irrespective	51.02358627319336	133.052978515625	9.96258544921875	238.03241348266602	52	NPGGFA+AdvTT3713a231
of an official recommendation and reimbursement for the	51.02358627319336	145.4683837890625	9.96258544921875	238.05633926391602	52	NPGGFA+AdvTT3713a231
vaccine. However, the absence of reimbursement may	51.02358627319336	157.9405517578125	9.96258544921875	238.09912490844727	52	NPGGFA+AdvTT3713a231
affect some parents’ decision, due to the cost, and therefore,	51.02358627319336	170.4127197265625	9.96917724609375	238.00949478149414	52	NPGGFA+AdvTT3713a231
this may lead to social inequality.	51.0225830078125	182.828125	9.96258544921875	136.22860717773438	52	NPGGFA+AdvTT3713a231
Conflict of Interest The authors Antoine Blanc, Yves Megard, and	51.02360153198242	224.89117431640625	8.4833984375	238.0910530090332	53	NPGGFB+AdvTTb8864ccf.B
Isabelle Bertand are full-time employees of Sanofi Pasteur MSD. This	51.02360534667969	234.82769775390625	8.46820068359375	238.0952911376953	53	NPGGFA+AdvTT3713a231
study was funded by a grant from Sanofi Pasteur MSD.	51.02360534667969	244.8057861328125	8.46820068359375	192.31619262695312	53	NPGGFA+AdvTT3713a231
References	51.02360153198242	280.94873046875	9.96258544921875	45.817996978759766	54	NPGGFB+AdvTTb8864ccf.B
Alfredsson R, Svensson E, Trollfors B, Borres MP (2004) Why do	51.02360153198242	307.1110534667969	8.468170166015625	238.1325569152832	55	NPGGFA+AdvTT3713a231
parents hesitate to vaccinate their children against measles,	67.97439575195312	317.0323791503906	8.46820068359375	221.17837524414062	55	NPGGFA+AdvTT3713a231
mumps and rubella? Acta Paediatr 93:1232–1237	67.97439575195312	327.0104675292969	8.473785400390625	169.83651733398438	55	NPGGFA+AdvTT3713a231
Centers for Disease Control and Prevention (CDC) (2003) Decline in	51.02275085449219	336.9885559082031	8.46820068359375	238.1122283935547	55	NPGGFA+AdvTT3713a231
annual incidence of varicella-selected states, 1990–2001.	67.97354125976562	346.9099426269531	8.4737548828125	221.17837524414062	55	NPGGFA+AdvTT3713a231
MMWR Morb Mortal Wkly Rep 52:884–885	67.97354125976562	356.8880310058594	8.4737548828125	156.7014923095703	55	NPGGFA+AdvTT3713a231
Flanagan-Klygis EA, Sharp L, Frader JE (2005) Dismissing the family	51.02189636230469	366.8661193847656	8.468170166015625	238.09532165527344	55	NPGGFA+AdvTT3713a231
who refuses vaccines: a study of pediatrician attitudes. Arch	67.97268676757812	376.8442077636719	8.468170166015625	221.11911010742188	55	NPGGFA+AdvTT3713a231
Padiatr Adolesc Med 159:929–934	67.97268676757812	386.7655334472656	8.473785400390625	119.62516784667969	55	NPGGFA+AdvTT3713a231
Fredrickson DD, Davis TC, Arnould CL, Kennen EM, Hurniston SG,	51.021881103515625	396.7436218261719	8.46820068359375	238.1138916015625	55	NPGGFA+AdvTT3713a231
Cross JT, Bocchini JA Jr (2004) Childhood immunization	67.97267150878906	406.7217102050781	8.46820068359375	221.10719299316406	55	NPGGFA+AdvTT3713a231
refusal: provider and parent perceptions. Fam Med 36:431–439	67.97267150878906	416.6997985839844	8.473785400390625	217.53282165527344	55	NPGGFA+AdvTT3713a231
Freed GL, Katz SL, Clark SJ (1996) Safety of vaccinations: Miss	51.02104187011719	426.6211853027344	8.468170166015625	238.0842742919922	55	NPGGFA+AdvTT3713a231
America, the media and the public health. JAMA 276:1869–1872	67.97183227539062	436.5992736816406	8.4737548828125	221.1436767578125	55	NPGGFA+AdvTT3713a231
J Public Health (2009) 17:71–76	431.71575927734375	33.05755615234375	8.4737548828125	112.555908203125	56	NPGGFA+AdvTT3713a231
Freed GL, Clark SJ, Hibbs BF, Santoli JM (2004) Parental vaccine	306.1382751464844	57.041015625	8.46820068359375	238.09951782226562	57	NPGGFA+AdvTT3713a231
safety concerns. The experiences of pediatricians and family	323.0890808105469	66.96234130859375	8.46820068359375	221.14529418945312	57	NPGGFA+AdvTT3713a231
physicians. Am J Prev Med 26:11–14	323.0890808105469	76.9404296875	8.4737548828125	129.90390014648438	57	NPGGFA+AdvTT3713a231
Freeman VA, Freed GL (1999) Parental knowledge, attitudes and	306.137451171875	86.91851806640625	8.46820068359375	238.08935546875	57	NPGGFA+AdvTT3713a231
demand regarding a vaccine to prevent varicella. Am J Prev Med	323.0882568359375	96.8966064453125	8.46820068359375	221.16729736328125	57	NPGGFA+AdvTT3713a231
17:153–155	323.0882568359375	106.81793212890625	8.4737548828125	40.367919921875	57	NPGGFA+AdvTT3713a231
Poland GA, Jacobson RM (2001) Understanding those who do not	306.1366271972656	116.7960205078125	8.46820068359375	238.09274291992188	57	NPGGFA+AdvTT3713a231
understand: a brief review of the anti-vaccine movement. Vaccine	323.0874328613281	126.77410888671875	8.46820068359375	221.11062622070312	57	NPGGFA+AdvTT3713a231
19:2440–2445	323.0874328613281	136.752197265625	8.4737548828125	48.854736328125	57	NPGGFA+AdvTT3713a231
Rasch G, Hellenbrand W (2004) Germany adds varicella vaccine to	306.1366271972656	146.67352294921875	8.46820068359375	238.11135864257812	57	NPGGFA+AdvTT3713a231
the National vaccination programme. Eurosurveillance Vol. 8,	323.0874328613281	156.651611328125	8.46820068359375	221.16146850585938	57	NPGGFA+AdvTT3713a231
issue 31. Available at: http://www.eurosurveillance.org/ew/2004/	323.0874328613281	166.62969970703125	8.46820068359375	221.09878540039062	57	NPGGFA+AdvTT3713a231
040729.asp	323.0874328613281	176.551025390625	8.46820068359375	38.71661376953125	57	NPGGFA+AdvTT3713a231
Robert Koch-Institut (2004a) Neue Empfehlungen der Ständigen	306.1366271972656	186.52911376953125	8.46820068359375	238.10879516601562	57	NPGGFA+AdvTT3713a231
Impfkommission veröffentlicht. Press release. 26 July. http://	323.0874328613281	196.5072021484375	8.46820068359375	221.10299682617188	57	NPGGFA+AdvTT3713a231
www.rki.de	323.0874328613281	206.48529052734375	8.46820068359375	39.16119384765625	57	NPGGFA+AdvTT3713a231
Robert Koch-Institut (2004b) Empfehlungen der Ständigen Impfkom-	306.1366271972656	216.4066162109375	8.46820068359375	238.17312622070312	57	NPGGFA+AdvTT3713a231
mission (STIKO) am Robert Koch-Institut/Stand: Juli 2004.	323.0874328613281	226.38470458984375	8.46820068359375	221.16397094726562	57	NPGGFA+AdvTT3713a231
Epidemiol Bull (30):235–250	323.0874328613281	236.36279296875	8.4737548828125	98.45721435546875	57	NPGGFA+AdvTT3713a231
Salmon DA, Moulton LH, Omer SB, deHart MP, Stokley S, Halsey	306.1366271972656	246.34088134765625	8.46820068359375	238.07400512695312	57	NPGGFA+AdvTT3713a231
NA (2005) Factors associated with refusal of childhood vaccines	323.0874328613281	256.26220703125	8.46820068359375	221.11990356445312	57	NPGGFA+AdvTT3713a231
among parents of school-aged children. Arch Pediatr Adolesc	323.0874328613281	266.2402648925781	8.468170166015625	221.10305786132812	57	NPGGFA+AdvTT3713a231
Med 159:470–476	323.0874328613281	276.2183532714844	8.4737548828125	62.87554931640625	57	NPGGFA+AdvTT3713a231
Sengupta N, Booy R, Schmitt HJ, Peltola H, Van-Damme P,	306.13665771484375	286.1964416503906	8.468170166015625	238.09527587890625	57	NPGGFA+AdvTT3713a231
Schumacher RF, Campins M, Rodrigo C, Heikkinen T, Seward	323.08746337890625	296.1177673339844	8.46820068359375	221.10467529296875	57	NPGGFA+AdvTT3713a231
J, Jumaan A, Finn A, Olcen P, Thiry N, Weil-Olivier C, Breuer J	323.08746337890625	306.0958557128906	8.46820068359375	221.13092041015625	57	NPGGFA+AdvTT3713a231
(2007) Varicella vaccination in Europe: are we ready for a	323.08746337890625	316.0739440917969	8.46820068359375	221.17333984375	57	NPGGFA+AdvTT3713a231
universal childhood programme? Eur J Pediatr 167(1):47–55,	323.08746337890625	325.9953308105469	8.4737548828125	221.1419677734375	57	NPGGFA+AdvTT3713a231
2008 Jan	323.08746337890625	335.9734191894531	8.468170166015625	30.924163818359375	57	NPGGFA+AdvTT3713a231
Taylor JA, Newman RD (2000) Parental attitudes toward varicella	306.13665771484375	345.9515075683594	8.468170166015625	238.047119140625	57	NPGGFA+AdvTT3713a231
vaccination. Arch Pediatr Adolesc Med 154:302–306	323.08746337890625	355.9295959472656	8.4737548828125	182.72427368164062	57	NPGGFA+AdvTT3713a231
Taylor JA, Darden PM, Brooks DA, Hendricks JW, Wasserman RC,	306.13665771484375	365.8509216308594	8.46820068359375	238.07073974609375	57	NPGGFA+AdvTT3713a231
Bocian AB (2002) Association between parents’ preferences and	323.08746337890625	375.8290100097656	8.473785400390625	221.1376953125	57	NPGGFA+AdvTT3713a231
perceptions of barriers to vaccination and the immunization	323.08660888671875	385.8070983886719	8.46820068359375	221.081787109375	57	NPGGFA+AdvTT3713a231
status of their children: a study from Pediatric Research in Office	323.08660888671875	395.7851867675781	8.46820068359375	221.13262939453125	57	NPGGFA+AdvTT3713a231
Settings and the National Medical Association. Pediatrics	323.08660888671875	405.7065734863281	8.468170166015625	221.1190185546875	57	NPGGFA+AdvTT3713a231
110:1110–1116	323.08660888671875	415.6846618652344	8.4737548828125	51.780517578125	57	NPGGFA+AdvTT3713a231
Wolfe RM, Sharp LK, Lipsky MS (2002) Content and design	306.1349792480469	425.6627502441406	8.468170166015625	238.07662963867188	57	NPGGFA+AdvTT3713a231
attributes of antivaccination websites. JAMA 287:569–575	323.0857849121094	435.5840759277344	8.473785400390625	201.71585083007812	57	NPGGFA+AdvTT3713a231
